Future virology, 2022-12, Vol.17 (12), p.849-862
- Thomas, Stephen J
- Moreira, Edson D
- Kitchin, Nicholas
- Absalon, Judith
- Gurtman, Alejandra
- Lockhart, Stephen
- Perez, John L
- Marc, Gonzalo Pérez
- Polack, Fernando P
- Zerbini, Cristiano
- Bailey, Ruth
- Swanson, Kena A
- Xu, Xia
- Roychoudhury, Satrajit
- Koury, Kenneth
- Bouguermouh, Salim
- Kalina, Warren V
- Cooper, David
- Frenck, Robert W
- Hammitt, Laura L
- Türeci, Özlem
- Nell, Haylene
- Schaefer, Axel
- Ünal, Serhat
- Yang, Qi
- Liberator, Paul
- Tresnan, Dina B
- Mather, Susan
- Dormitzer, Philip R
- Şahin, Uğur
- Gruber, William C
- Jansen, Kathrin U
2022
Volltextzugriff (PDF)
Details
- Autor(en) / Beteiligte
- Thomas, Stephen J
- Moreira, Edson D
- Kitchin, Nicholas
- Absalon, Judith
- Gurtman, Alejandra
- Lockhart, Stephen
- Perez, John L
- Marc, Gonzalo Pérez
- Polack, Fernando P
- Zerbini, Cristiano
- Bailey, Ruth
- Swanson, Kena A
- Xu, Xia
- Roychoudhury, Satrajit
- Koury, Kenneth
- Bouguermouh, Salim
- Kalina, Warren V
- Cooper, David
- Frenck, Robert W
- Hammitt, Laura L
- Türeci, Özlem
- Nell, Haylene
- Schaefer, Axel
- Ünal, Serhat
- Yang, Qi
- Liberator, Paul
- Tresnan, Dina B
- Mather, Susan
- Dormitzer, Philip R
- Şahin, Uğur
- Gruber, William C
- Jansen, Kathrin U
- Titel
- Plain Language Summary of Pfizer-BioNTech BNT162b2 COVID-19 Vaccine Safety in Participants at Least 16 Years Old and Protection Against COVID-19 in Participants at Least 12 Years Old
- Ist Teil von
- Future virology, 2022-12, Vol.17 (12), p.849-862
- Erscheinungsjahr
- 2022
- Sprache
- Englisch
- Identifikatoren
- ISSN: 1746-0794eISSN: 1746-0808DOI: 10.2217/fvl-2022-0142Titel-ID: cdi_crossref_primary_10_2217_fvl_2022_0142
- Format
- –